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ABSTRACT: Investigating the binding interaction of small
molecules to large ligands is a compelling task for the field of
drug development, as well as agro-biotechnology, since a common
trait of drugs and toxins is often a low molecular weight (MW).
Here, we improve the limit of detection of the Interferometric
Reflectance Imaging Sensor (IRIS), a label-free, highly multiplexed
biosensor, to perform small-molecule screening. In this work,
characterization of small molecules binding to immobilized probes
in a microarray format is demonstrated, with a limit of detection of
1 pg/mm2 in mass density. First, as a proof of concept to show the
impact of spatial and temporal averaging on the system noise,
detection of biotin (MW = 244.3 Da) binding to a streptavidin-
functionalized chip is performed and the parameters are tuned to
achieve maximum signal-to-noise ratio (SNR ≈ 34). The optimized system is then applied to the screening of a 20-multiplexed
antibody chip against fumonisin B1 (MW = 721.8 Da), a mycotoxin found in cereal grains. The simultaneously recorded binding
curves yield an SNR ≈ 8. Five out of twenty antibodies are also screened against the toxin in a lateral flow assay, obtaining consistent
results. With the demonstrated noise characteristics, further sensitivity improvements are expected with the advancement of camera
sensor technology.
1. INTRODUCTION
The ability to measure small-molecule binding kinetics is a
critical issue in pharmacology research. In 2019, the Federal
Drug Administration (FDA) approved 48 new drugs, 73% of
which belong to the category of small molecules, defined as an
ensemble of the chemical compounds with a molecular weight
(MW) below 1 kDa.1,2 On the same level, most of the
microfungi-produced toxins that are commonly known to
affect many varieties of crops also fit this description, which
makes small-molecule detection ability of utmost importance
in the food industry as well. Since the most established drug
and toxin detection methods are antibody-based, both in point
of care systems and in industry, characterization of the affinity
of the small molecules to monoclonal antibodies is crucial to
determine the best capture probe for the unambiguous
screening of complex specimens, like bodily fluids or food
samples.
The low molecular weight that characterizes these
compounds facilitates access to the cell through the cellular
membrane, where an effect (either beneficial for medicines or
harmful for toxins) can be produced. However, while the small
size of these molecules benefits function, it also makes
detection difficult. In label-free sensing, molecular binding,
especially for small-molecular weight (MW) analytes, generates
a very small optical response. Labeling small molecules with
either a fluorescent tag3,4 or a metallic nanoparticle5,6 makes
them easier to detect. However, most of these techniques lack
kinetic capabilities. Moreover, efficient labeling of such small
compounds is an invasive process that can cause changes in the
molecule’s functionality, especially if the tag is much larger in
size.7
Label-free techniques are, therefore, preferred when it comes
to evaluating the kinetic behavior of drugs, toxins, and small
analytes in general, against specific capture probes. Among
these methods, surface plasmon resonance (SPR) is one of the
most widely employed.8 SPR achieves a good sensitivity, for
both small and large molecules.9 However, SPR measurements
can be challenging, due to environmental factors that inevitably
increase the noise of the measurements, such as the change in
the refractive index of the solution, caused by solvents,
temperature changes, or pH variations. Moreover, traditional
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SPR instruments often lack multiplexing capabilities, making
the comparison of different ligands difficult. Surface plasmon
resonance imaging (SPRi), on the other hand, allows for
multiplexing but in return sacrifices sensitivity, which worsens
by an order for magnitude from traditional SPR, as broadly
discussed in Section 3.2.10 These considerations emphasize
both the challenge and the need for an effective and simple
quantification of small-molecule−probe interactions.
Here, we demonstrate a highly sensitive optical method to
detect the binding of small-molecule analytes to their ligands.
By combining the well-known technique of the interferometric
reflectance imaging sensor (IRIS)11 with noise reduction
algorithms and procedures, we increase the signal-to-noise
ratio and enable small-molecule sensitivity, shown for a small
molecule of a molecular weight (MW) of 244.3 Da (biotin).
The optimization process described in this work leads to a
sensitivity of ≈1 pg/mm2 in terms of biomass accumulation
detection, and the measured signal is shown to be shot noise-
limited, which leaves even further potential for improvement
with imaging sensor technology, as explained in Section 2.1.2.
We show the application of the optimized sensor to the
detection and characterization of a low-molecular-weight
mycotoxin (fumonisin B1, MW = 721.8 Da) on a 20-
multiplexed chip, achieving a signal-to-noise ratio of ≈8. On
the 20-multiplexed chip, 20 spots were devoted to each probe,
proving that the current IRIS system allows for character-
ization of up to 400 ligands on the same support, a level of
multiplexing that could be even further extended through
incorporation of a camera with a larger imaging sensor size.
2. RESULTS
2.1. Noise Reduction and System Optimization. To
detect small molecules binding to their ligands, the system
noise must be lower than the change in signal that occurs due
to the addition of the small MW analyte to the large MW
ligand. The reflectance signal measured in the IRIS system is
captured by a scientific-grade camera designed to have low
noise characteristics. Despite this, CMOS sensors can be
vulnerable to dark current noise (which is temperature-
dependent), read noise (sensor design-dependent), and fixed
pattern noise (fabrication quality-dependent). In addition to
these, shot noise, which originates from the discrete nature of
the electric charge, can dominate in bright images. In shot
noise-limited operation, the signal-to-noise ratio (SNR)
increases with √N, where N is the number of electrons;
therefore, increasing the number of electrons captured can lead
to drastic improvements in the SNR. In CMOS sensors, the
number of electrons that we can collect corresponds to the full-
well capacity (FWC) of the pixels. However, the FWC cannot
be increased infinitely, and therefore, shot noise cannot be
effectively reduced through imaging sensor selection alone. To
improve noise beyond the FWC, electrons from nearby pixels
in both time and space can be combined through averaging to
further minimize the noise.
2.1.1. IRIS Characterization of Biotin−Streptavidin Inter-
action. Here, the biotin−streptavidin interaction is used as a
proof of concept to demonstrate the level of detection of our
sensor, as well as to optimize the acquisition and analysis
parameters to achieve the best possible sensitivity. The biotin−
streptavidin interaction is commonly utilized in a variety of
biophysical methods to strongly anchor molecules to a surface,
as it is one of the strongest noncovalent interactions in
nature.12 Biotin belongs to the above-defined category of small
molecules, with a molecular weight of only 244.3 Da.
For this experiment, streptavidin molecules were immobi-
lized in a microarray modality on IRIS chips, at a spotting
concentration of 18 μM. Biotin was flowed across the
streptavidin spots at a 1 μM concentration for 20 min, at a
flow rate of 200 μL/min. The binding of the biotin molecules
to the streptavidin probes is extremely fast, as is expected if one
considers the very low KD of the interaction (≈1 pM).
Therefore, the obtained binding curve has the appearance of a
step (Figure 1).
2.1.2. Temporal and Spatial Averaging. Temporal and
spatial averaging were employed to minimize the noise,
quantified as the standard deviation over the signal. Figure
2a,2b shows the theoretical noise reduction expected from
temporal and spatial averaging in a shot noise-dominated
model, as well as the actual noise reduction observed in the
biotin−streptavidin experiment shown in Figure 1. Figure 2a
depicts the standard deviation over the signal of a single pixel
with an increasing number of averaged frames, confirming the
noise dependence on √N. Using this information, 100 frames
were chosen as the optimal number of frames for averaging to
maximize noise reduction while maintaining sufficient
temporal resolution. Figure 2b shows the standard deviation
over the average signal when 100 frames were averaged,
beginning with averaging the pixels within a single microarray
spot (5024 pixels) and increasing the number of spots
Figure 1. Effect of averaging on a streptavidin−biotin experiment.
Biotin was flowed at a concentration of 1 μM across a chip where 50
streptavidin spots were previously printed. (a) Biotin signal without
spatial averaging (single spots) (b) compared to biotin signal with
spatial averaging (50 spots). Temporal averaging was fixed at 100
frames/image.
Figure 2. Effect of averaging on the IRIS signal. Theoretical and
experimental reduction in the noise level due to (a) temporal
averaging and (b) spatial averaging.
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averaged, with each spot contributing an additional 5024 pixels
of electrons. The deviation in the experimental trend from the
theoretical trend in Figure 2b can be attributed to dynamic
changes on the chip surface and fluidic movement of the
system.
Figure 1 shows the SNR improvement from applying the
studied noise reduction methods in the biotin−streptavidin
experiment. One hundred frames were averaged in time for
each image in the experiment, and 50 microarray spots (5024
pixels each) were analyzed. The data in Figure 1a shows the
average signal value for each of these 50 microarray spots.
When these 50 microarray spots are averaged together, the
result, seen in Figure 1b, shows a clear binding step and an
SNR of 34. The noise level achieved was 1 pg/mm2, which
could be easily improved with more averaging (spatial or
temporal).
2.2. Application of the Optimized IRIS System to
Detection of Toxins. Toxins are poisonous substances
produced by living organisms and many fall into the previously
defined category of small molecules. In particular, mycotoxins
are low-molecular-weight (<800 Da) secondary metabolites
produced by microfungi (molds). These naturally produced
compounds can be easily found in fresh produce, as a result of
fungal infection of crops. Mycotoxins are harmful to both
humans and animals, provoking diseases (mycotoxicoses),
which might lead to cancer formation13,14 and sometimes
death. Given the serious effects that they provoke on human
health, the food industry is facing the critical issue of trying to
detect the presence of these toxins in food products during
quality control procedures.
2.2.1. Real-Time IRIS Screening of a 20-Multiplexed Chip
against Fumonisin B1. In this work, we applied the noise-
optimized IRIS system to the study of the binding kinetics of
Fumonisin B1, a 721.8 Da mycotoxin produced by the
Fusarium fungal species. This fungus usually attacks corn crops
and acts by weakening the core structure of corn cobs.
For these experiments, twenty antibodies that tested positive
to the toxin in an ELISA assay were immobilized onto an IRIS
chip, where twenty spots were devoted to each antibody, for a
total of 440 active spots that were imaged simultaneously
(Figure 3, 20 antibodies, each printed on 20 equal spots and 40
control spots). Each antibody was spotted at a different
spotting concentration, due to different purification yields, and
the spots appear with different initial intensities, as shown in
Figure 3; thus, the steady-state signal level may not be
predictive of binding kinetics.
Fumonisin at a concentration C0 = 100 μM was flowed
across the surface of the chip for 20 min at 200 μL/min,
followed by PBS-1X at 200 μL/min for 20 more min. The
binding was detected on 18 out of the 20 antibodies, and
representative binding curves are reported in Figure 4. A
simple 1:1 Langmuir model15 was used to fit the curves and
obtain the association and dissociation constants (Table S1).
The remaining 14 binding curves are reported in the
Supporting Information (Figures S1 and S2).
From our measurements, the antibodies produced with
fumonisin B1-CTxB seem to have a higher affinity to
fumonisin B1. Particularly, the antibody that we have labeled
as CTx5 has the highest association constant and lower
equilibrium constant (KD).
2.2.2. Lateral Flow Assay Measurements for Detection of
Fumonisin B1 Toxin. A competitive lateral flow (LF) assay was
performed as a validation step to determine the reactivity of
the monoclonal antibodies to fumonisin B1. The results are
reported for five clones in Table S2. For these experiments, the
amount of fumonisin antibody-coated gold nanoparticles
bound to a fumonisin B1−IgG conjugate test line was
quantified in the absence and presence of 4.8 ppm (≈5.5
μM) of fumonisin B1, as described in Experimental Section
5.5. The intensity of the quantified signal in the absence and
presence of the toxin is indicated as a percentage ( B
B0
%). The
lower the percentage, the higher the sensitivity of the antibody
to the toxin. These results demonstrate that the antibodies
from the CTxB subset have a higher sensitivity for the toxin, in
accordance with the IRIS data. Moreover, KLH2 and KLH7
were the least reactive of the antibodies that were tested on the
lateral flow reader, as well as showing very little binding on the
IRIS platform.
3. DISCUSSION
3.1. Analysis of the Noise Levels and Potential for
Improvement. The signal measured in the IRIS system is
Figure 3. IRIS image of the 440 antibody spots on one of the chips
used for the experiments. The first and 12th columns are devoted to
the control (bovine IgG), columns 2−11 are devoted to fumonisin
B1-CTxB antibodies (CTx1-10), and columns 13−22 are devoted to
fumonisin B1-KLH antibodies (KLH1-10). The different intensity of
the spots is due to differences in concentration of the spotted samples.
Figure 4. Binding and debinding curves of the fumonisin B1 toxin at a
concentration of 100 μM to six different antibodies. The association
part of the fit is shown in the red, solid line. The dissociation part is
shown in the blue, solid line. The control spots’ trend is shown in the
black, dotted line.
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electronic from the CMOS camera, lending itself to
straightforward analysis in units of electrons. However, for a
more practical quantification of sensitivity, these values are
converted to biomass. The black-colored line in Figure 5 shows
the relationship between the signal measured at the CMOS
camera and the amount of biomass accumulation on the IRIS
sensor surface.16 Both the change in signal as a result of a
binding event and noise levels in relation to total signal are
displayed in this figure. To observe a binding event, the
binding signal must be higher than the signal noise. The noise
level of a single pixel, without any improvements from spatial
and temporal averaging, is labeled S0 in Figure 5. This noise
level of 3 ng/mm2 prevents the observation of larger molecules
such as antibodies (150 kDa). With the averaging optimiza-
tions explored in this study, the sensitivity improves by
multiple orders of magnitudes to 1 pg/mm2, with the potential
for further improvements.
The camera used in these experiments (GS3-U3-51S5M-C)
has an FWC of 10,361, a frame rate of 38 fps, and an image
sensor size of 5,013,504 pixels, which dictate the potential for
shot noise reduction in this system. The FWC describes the
number of photons that can be collected by each pixel, and
therefore, the base shot noise. The frame rate dictates the
number of frames that can be averaged temporally and still
maintain the temporal resolution needed to quantify the
binding event of interest. The size of the image sensor
determines how many pixels are available for spatial averaging;
though, spatial averaging limits the number of different
molecules that can be measured simultaneously, diminishing
the multiplexing capabilities of IRIS. The results of this study
provide guiding principles for optimizing IRIS experiments.
The number of electrons needed for desired sensitivity levels,
and therefore, the pixels and frames to average, determine the
experimental parameters such as spot size (pixels) and
temporal resolution (frames). When detecting small amounts
of biomass accumulation, utilizing more of the sensor surface
or lowering temporal resolution can allow for great increases in
sensitivity.
In the proof-of-concept biotin−streptavidin experiments
described above, only 271,286 out of the available 5,013,504
pixels were used to image the streptavidin spots, resulting in a
fill factor of only 5% and a sensitivity defined by the noise floor
of 1 pg/mm2. A 40% fill factor can be comfortably achieved,
and therefore, with the currently implemented camera utilizing
a 40% fill factor and filling the FWC to 75% and averaging 100
frames, the maximum sensitivity that can be achieved is 0.202
pg/mm2.
Future implementation of improved CMOS technology will
greatly increase the SNR in these experiments. For example,
the FLIR BFS-U3-17S7M, a 1.1″ format CMOS, has an FWC
of 98,654, and therefore lower baseline shot noise. It also has a
frame rate of 152 fps at 12 bit image capture, allowing for
greater temporal averaging with the same experimental
temporal resolution, and a camera sensor size of 1,760,000
pixels, allowing for significant spatial averaging. With this
proposed camera, filling the FWC to 75%, utilizing a 40% fill
factor, and averaging 400 frames (for the same temporal
resolution), the maximum sensitivity that can be achieved is
0.0559 pg/mm2. Table S3 shows a more detailed comparison
of the two above-mentioned camera technologies. Figure 5
shows the improvement in sensitivity for the camera used in
these experiments and the proposed camera technology, as well
as the signal levels for the biotin−streptavidin interaction and
fumonisin achieved in these experiments, and the signal level
for a typical IgG antibody.
The signal levels reached with the binding of biotin and
fumonisin to the sensor surface as shown in Figure 5 are in
good accordance with the expected values, as further described
in Section 1 of the Supporting Information. There, a more
deep discussion around the connection between the molecular
structure of the probe, the chemical structure of the surface,
and binding efficiency of the analyte is carried out.
3.2. Limit of Detection with Respect to Other Label-
Free Technologies. In the world of label-free detection and
small-molecule characterization, surface plasmon resonance
(SPR) is by far the most widely employed technique. Other
technologies1,7,18,19 are rapidly gaining popularity, but, never-
theless, SPR is still considered to be the gold standard of the
field. Therefore, we have decided to focus our analysis on the
comparison between the SPR and the IRIS technology.
As mentioned in the Introduction, SPR technology is based
on signal amplification and therefore has a very high sensitivity,
able to detect less than 1 pg/mm2 in mass density.9 However,
SPR suffers from environmental factors, like refractive index
changes caused by solvents or temperature shifts, requiring the
use of an additional channel as a blank to correct for unwanted
effects. Moreover, SPR cannot provide multiplexed measure-
ments, and instead, a more complex version of SPR is normally
used, namely, surface plasmon resonance imaging (SPRi). SPRi
can provide multiplexed measurements up to thousands of
probes. However, the limit of detection of SPRi increases to
≈7 pg/mm2 in spectral mode and ≈30 pg/mm2 in reflective
mode.10 SPRi is therefore not suited for small-molecule
characterization, whichdepending on the affinity of the
reactioncan lead to a total accumulated biomass below its
limit of detection.
To compare these techniques to the IRIS, we will now
summarize the results presented in Sections 2.1 and 2.2 to
define its sensitivity and limit of detection. Thanks to the
averaging procedures and optimization process described in
Section 2.1.2, both binding measurements of a single analyte to
Figure 5. Change in the reflectance signal and the relation to biomass
accumulation. S0 shows the sensitivity of IRIS without any spatial and
temporal averaging. Scurrent marks the ultimate sensitivity in terms of
noise achievable with the current camera (FLIR GS3-U3-51S5) and
Sfuture marks the ultimate sensitivity achievable with the proposed new
camera (FLIR BFS-U3-17S7M) discussed further in the text. These
values are shown in relation to the signal levels measured for biotin
and fumonisin found in these studies, as well as a typical IgG
antibody.17
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a single probe and multiplexed measurements have demon-
strated small-molecule sensitivity. An SNR of ≈34 has been
obtained for binding of biotin to a streptavidin-functionalized
chip, with a noise level of 1 pg/mm2, comparable to traditional
SPR. For what concerns multiplexed measurements, a standard
noise of 1.5 pg/mm2 has been demonstrated for a 20-
multiplexed chip with 440 spots imaged simultaneously,
achieving small-molecule sensitivity as well as multiplexing, a
net improvement with respect to conventional SPRi.
Furthermore, the IRIS presents a non-negligible cost
advantage. The cost of the whole IRIS cartridge is <$5,
while SPR consumables are upward of $200. Si-based
microfluidics has highly scalable production capabilities due
to the well-established semiconductor fabrication industry, and
as a result, the cost of each cartridge can be as little as $2 in
large volumes.20
4. CONCLUSIONS
To conclude, we have demonstrated a multiplexed, highly
sensitive label-free optical detection technique for measuring
small-molecule binding kinetics achieved through noise
reduction methods. Quantitatively, the results obtained with
the IRIS in terms of biomass accumulation are in accordance
with the theoretical predictions, as shown in Section 1 in the
Supporting Information. The lateral flow findingsalthough
limitedare in good accordance with the IRIS data, thus
confirming the screening capabilities of the IRIS technology.
Most importantly, the IRIS allowed us to accurately estimate
the affinity of fumonisin for 18 out of 20 antibodies,
information that the lateral flow reader was unable to provide.
Since our technique relies on improving the measurement
fidelity through temporal and spatial averaging, further
improvements in sensitivity are expected as camera tech-
nologies advance and provide a faster frame rate, larger full-
well capacity per pixel, and larger camera sensor. The increased
sensitivity afforded by these advancements would allow for
detection of even smaller amounts of biomaterial accumu-
lation, enabling characterization of smaller-sized molecules at
lower concentrations.
5. EXPERIMENTAL SECTION
5.1. Interferometric Reflectance Imaging Sensor
(IRIS). The working principle of IRIS has been extensively
described earlier.11 Briefly, a silicon substrate with a thin layer
of SiO2 is illuminated from the top with a light-emitting diode
(LED) in a common-path interferometer configuration, and
the reflected image is captured with a camera (Figure S5).
While a single color LED is used for data acquisition, four
images are acquired prior to each experiment by subsequently
illuminating the chip with each of four narrowband LEDs with
distinct central wavelengths (457, 518, 595, and 632 nm).
These four-color images are taken as a calibration step to allow
for conversion from reflectance signal-to-mass density values.16
The color of the LED used for data acquisition is selected in
accordance with the specific thickness of the oxide layer. For
example, for 110 nm of oxide, blue (457 nm) produces the
largest signal for biomass accumulation. An adhesive 130 μm-
thick spacer and a coverglass are applied to the substrate,
creating a fluidic chamber (Figure S6). Laser-drilled through-
holes on each end of the SiO2/Si substrate allow for fluids to
enter the chamber, flow across the chip, and exit. An
antireflection coating is applied on the coverslip to minimize
reflection from the air−glass interface. The cartridge thus
composed is imaged through the solution, allowing for
monitoring of unwanted effects such as refractive index
changes. The images are acquired by a CMOS camera, in
this study the FLIR Grasshopper GS3-U3-51S5M-C.
5.2. Image Analysis. The real-time videos are analyzed in
ImageJ through a custom-made plugin. Briefly, two regions of
interest are considered for each spot: the spot itself (Sspot) and
a donut-shaped region around it, to be used as background
(Sbg). By measuring the differential change in signal ΔS = Sspot
− Sbg, the binding curves are generated. Further postprocessing
analysis is performed in MATLAB, where the data are fitted
with the model of choice (in the case of fumonisin, a simple
Langmuir 1:1 binding model is used). Moreover, both during
acquisition and in postprocessing, temporal and spatial
averaging are applied to the acquired data to increase the
signal-to-noise ratio and improve the limit of detection, as
further discussed in Section 2.1.2.
5.3. Chip Surface Functionalization. The chips are
functionalized by printing the molecular probes on the surface
in a microarray modality. Spot printing is performed with the
M2 iTWO-300P High precision microarray-dispensing instru-
ment (Berlin, Germany). Prior to spotting, the surface of the
chips is activated with an N,N-dimethylacrylamide (DMA)-
based polymer, commercially known as MCP-2 (Lucidant
Polymers, LLC, Sunnyvale, CA).21 Briefly, the chips are first
activated with oxygen plasma for 10 min, then immersed in the
aqueous polymer solution (1% w/v polymer in 20% saturated
ammonium sulfate) for 30 min. The chips are then rinsed with
DI water, gently dried with a nitrogen stream, and finally dried
in a vacuum oven at 80 °C for 15 min. Spotting of the probes is
subsequently performed, and after deposition, the chips are left
in the spotter at 70% humidity overnight. Prior to starting the
experiment, the chips are blocked with a 50 mM ethanolamine
solution in 100 mM tris-HCl (pH = 9).
5.4. Chemical and Biological Materials. All buffers and
reagents were purchased from Sigma-Aldrich (St. Louis, MO).
Fumonisin and fumonisin antibody samples were provided by
Neogen, Inc. Fumonisin B1 was provided as a powder and
dissolved in 50/200 mM PBS (pH = 7.5) at a final
concentration of 100 μM. Monoclonal antifumonisin antibod-
ies were purified from cell culture supernatants by Protein-G
chromatography. The antibodies were generated by immuniz-
ing mice with fumonisin B1 conjugated to either Cholera toxin
B subunit (CTxB) or to Keyhole Limpet Hemocyanin (KLH).
The antibodies were immobilized on the chips at purification
concentration. Biotin was dissolved in DMSO at a concen-
tration of 100 mM, diluted in PBS at 1 mM, and subsequently
diluted at 1 μM.
5.5. Lateral Flow Reader. All lateral flow assay measure-
ments were quantified with the Raptor Solo Integrated
Analysis Reader (Neogen Corporation). The data was
downloaded from the reader as an Excel file using the Data
Manager application provided by Neogen.
In general, an LF device consists of a glass fiber pad
(conjugate pad) overlapping a nitrocellulose membrane
capped with an absorbent (wicking) pad (Figure S8).
Antibody-coated gold nanoparticles are dispensed onto the
conjugate pad and an antibody-specific binding reagent (test
line) is dispensed on the nitrocellulose. The application of a
liquid sample to the gold conjugate pad initiates the capillary
flow of the sample through the pad and the wicking pad draws
the sample through the conjugate pad and onto the
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nitrocellulose. In the absence of the analyte in the sample, the
gold particles bind to the test line resulting in a dense colored
line. If the sample contains the analyte, the antibody-coated
gold particles will preferentially bind to the analyte, thus
decreasing the amount of gold that can bind to the test line.
The result is a less dense test line. The test line density will
vary depending on the concentration of the analyte in the
sample, as well as the binding affinity of the antibody-coated
gold nanoparticle to the analyte.
With regards to the LF device used in the experiments
described herein, each antifumonisin B1 monoclonal antibody
was passively coated onto 40 nm gold nanoparticles (10 μg of
antibody per OD of gold solution), and 0.02 OD gold was
dispensed onto the conjugate pad of an LF device. The test
line striped onto the nitrocellulose membrane was a fumonisin
B1−IgG conjugate (0.4 μg per device). For the assay,
nondetect (ND) corn matrix and corn matrix contaminated
with fumonisin B1 at 4.8 ppm (Trilogy Analytical Laboratory)
were extracted and the assay was performed according to the
kit instructions for the DON Q+ Lateral Flow Assay (Neogen).
The assay was performed at ambient temperature for 5 min. In
the absence of fumonisin B1, the test line (TL) forms a solid
line. The TL intensity is diminished in the presence of
fumonisin B1. Test Line intensity in the absence and presence
of fumonisin B1 was quantified with the Lateral Flow Reader,
and the antibody sensitivity to fumonisin B1 was assessed by
calculating the binding percentage ( %B
B0










where TLB1 indicates the TL intensity in the presence of




The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsomega.0c03708.
Binding and debinding curves of fumonisin B1 to a
multiplexed chip, and respective association and
dissociation constants; lateral flow results; comparison
with a model for theoretical mass accumulation values;




Elisa Chiodi − Department of Electrical Engineering, Boston
University, Boston, Massachusetts 02215, United States;
orcid.org/0000-0003-2036-4584; Email: elich@bu.edu
Authors
Allison M. Marn − Department of Electrical Engineering, Boston
University, Boston, Massachusetts 02215, United States
Matthew T. Geib − Department of Electrical Engineering,
Boston University, Boston, Massachusetts 02215, United States
Fulya Ekiz Kanik − Department of Electrical Engineering,
Boston University, Boston, Massachusetts 02215, United States
John Rejman − Neogen Corp., Lansing, Michigan 48912,
United States
David AnKrapp − Neogen Corp., Lansing, Michigan 48912,
United States
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